Resources

This report analyzes the investments made by the Government of Kenya into health R&D and demonstrates the importance of developing an investment case for R&D to support future advocacy aimed at enhancing investments in Kenya.

This document shares learnings from an assessment of the global syringe market capacity to help ensure production volumes can be secured with no delay for the 92 low and lower middle income countries that will be rolling out vaccines under the COVAX Advance Market Commitment. Products covered include auto disable and reuse prevention syringes, prefilled delivery devices, and safety boxes. This brief was completed in December, 2020.

COVID-19 has disrupted the delivery of essential services worldwide, including in places that are already battling other epidemics. This brief describes how the USAID/Afya Ziwani project in Western Kenya adapted the implementation of DREAMS programming, which provides HIV prevention services for adolescent girls and young women, to ensure continuity of services during the COVID-19 pandemic.

Cryptosporidiosis has been recognized as one of the leading causes of morbidity and mortality from diarrhea in children under 5 years of age in low-resource settings. Despite the magnitude and significance of the problem, only a single drug is approved to treat Cryptosporidium infection, and new therapies are urgently needed.The third Symposium on Innovative Therapeutics for Cryptosporidium puts the spotlight on Crypto. Similar to the first two meetings hosted by PATH in San Francisco, California (2016) and Seattle, Washington (2018), this convening assembles leading researchers to present and discuss the current state of work on Crypto— from early discovery to clinical development and commercialization, veterinary medicine, diagnostics, and vaccines. Our goal is to share research, highlight opportunities for collaboration, and spark innovation toward making new and improved therapies a reality. This document summarizes the event's scientific program.

A reliable supply chain is often referred to as the “backbone” of a health system. In addition to meeting the demand for drugs and medical supplies, it serves to safeguard a country’s investments in health commodities, which is particularly important as countries ramp up efforts to work toward universal health coverage.The aim of this Journey of the Pill assessment is to identify strengths and inefficiencies in the supply chain in Ghana. It builds on PATH’s earlier supply chain assessment in Kenya. Further defining the journey of medicines will help inform the Ministry of Health and other stakeholders of future actions to strengthen commodity security for noncommunicable diseases.